Eli Lilly CEO David Ricks bought just over $1 million of Lilly shares in the open market Tuesday following the sharp drop in ...

CNBC’s Angelica Peebles and Eli Lilly chairman and CEO David Ricks join 'Squawk Box' to discuss the company's quarterly earnings results, late-stage trial data on its experimental obesity pill ...

Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

For now, Lilly's insiders put money where their mouths are, betting the selloff overreacts to interim noise and that the ...

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

One of them is the pharmaceutical industry. However, some major executives in the sector are not optimistic, including Eli Lilly 's (NYSE: LLY) CEO, David Ricks. Start Your Mornings Smarter!

As President Donald Trump works to move sky-high U.S. drug prices closer to those in other developed countries, Eli Lilly ...

When David Ricks became CEO of Eli Lilly, he faced the usual pressures of making the right, albeit risky, bets on the next big pharmaceutical breakthrough. But he also faced a unique challenge ...

One of them is the pharmaceutical industry. However, some major executives in the sector are not optimistic, including Eli Lilly 's (NYSE: LLY) CEO, David Ricks. Start Your Mornings Smarter!